KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Assets Average (2018 - 2025)

Historic Assets Average for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $515.0 million.

  • Aurinia Pharmaceuticals' Assets Average fell 398.92% to $515.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $515.0 million, marking a year-over-year decrease of 398.92%. This contributed to the annual value of $549.4 million for FY2024, which is 783.03% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Assets Average of $515.0 million as of Q3 2025, which was down 398.92% from $503.7 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Assets Average's 5-year high stood at $552.0 million during Q3 2023, with a 5-year trough of $373.2 million in Q3 2021.
  • For the 5-year period, Aurinia Pharmaceuticals' Assets Average averaged around $494.8 million, with its median value being $503.7 million (2025).
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Assets Average skyrocketed by 4124.57% in 2021 and then tumbled by 1215.38% in 2023.
  • Aurinia Pharmaceuticals' Assets Average (Quarter) stood at $451.7 million in 2021, then increased by 6.17% to $479.6 million in 2022, then rose by 15.01% to $551.5 million in 2023, then decreased by 0.28% to $550.0 million in 2024, then fell by 6.36% to $515.0 million in 2025.
  • Its Assets Average was $515.0 million in Q3 2025, compared to $503.7 million in Q2 2025 and $527.7 million in Q1 2025.